Institutional investors purchased a net $3.7 million shares of ADXS during the quarter ended October 2014 and now own 42.43% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 1.2 Million shares of Advaxis Inc
ADAGE CAPITAL MANAGEMENT LP Bought 684.8 Thousand shares of Advaxis Inc